{
  "id": "623345bf3a8413c6530000ab",
  "type": "factoid",
  "question": "LINC00339 is a diagnostic, prognostic and treatment efficacy biomarker for what disease?",
  "ideal_answer": "LINC00339 as a cancer diagnostic, prognostic and treatment efficacy biomarker.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31239716",
    "http://www.ncbi.nlm.nih.gov/pubmed/31269584",
    "http://www.ncbi.nlm.nih.gov/pubmed/28171565",
    "http://www.ncbi.nlm.nih.gov/pubmed/34741346",
    "http://www.ncbi.nlm.nih.gov/pubmed/31188482",
    "http://www.ncbi.nlm.nih.gov/pubmed/31128030",
    "http://www.ncbi.nlm.nih.gov/pubmed/34105151",
    "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
    "http://www.ncbi.nlm.nih.gov/pubmed/32991297",
    "http://www.ncbi.nlm.nih.gov/pubmed/31081143",
    "http://www.ncbi.nlm.nih.gov/pubmed/29499931",
    "http://www.ncbi.nlm.nih.gov/pubmed/30485513",
    "http://www.ncbi.nlm.nih.gov/pubmed/29906749",
    "http://www.ncbi.nlm.nih.gov/pubmed/32308105",
    "http://www.ncbi.nlm.nih.gov/pubmed/33235461",
    "http://www.ncbi.nlm.nih.gov/pubmed/31781497"
  ],
  "snippets": [
    {
      "text": "Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Through microarray data, Linc00339 was identified as a candidate oncogenic lncRNA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE: To investigate the role and mechanism of long non-coding (lnc) RNA LINC00339 in pancreatic cancer (PANC), and provided a potential target for its biological diagnosis and trea",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31128030",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " showed that LINC00339 was significantly up-regulated in NSCLC tissue and cells, which indicated the poor prognosis of NSCLC patients. Loss-o",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29906749",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "(HCC). The lncRNA LINC00339 was reported to regulate the development of lung cancer or breast",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31239716",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "we demonstrated that LINC00339 was upregulated in glioma tissue as well as in glioma cell lines. The e",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29499931",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "LINC00339 promotes cell proliferation and metastasis in pancreatic cancer via miR-497-5p/IGF1R axis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31128030",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Introduction: Accumulating evidence has indicated that long noncoding RNAs (lncRNAs) are pivotal regulators involved in the pathogenesis of cancer; however, the molecular mechanism of LINC00339 in colorectal cancer (CRC) remain",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33235461",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "vasion. Xenograft experiment was used to test tumor growth in vivo. Results: LINC00339 overexpression was correlated with an advanced stage, metastasis, and bad prognosis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31239716",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Endometriosis risk alleles at 1p36.12 act through inverse regulation of CDC42 and LINC00339",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28171565",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31081143",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "ugh microarray data, Linc00339 was identified as a candidate oncogenic lncRNA. We ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " in vivo experiments, Linc00339 overexpression promoted triple-negative breast cancer (TNBC) proliferation, inhibited cell cycle arrest, and suppressed apoptosis. Silencing of Linc00339 ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "pared the expression levels of Linc00339 in several breast cancer cell lines and normal mammary gland epithelial cell line. The ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "work identified a 5-lncRNA signature (ENSG00000206567, PCAT29, ENSG00000257989, LOC388282, and LINC00339) from TCGA training studies (n = 1,878). The identifie",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32991297",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "fects of Linc00339 on tumor progression were examined both in vitro and in vivo. 3-(4",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "LINC00339 expression in colorectal cancer tissues and adjacent colorectal sampleswas detected by Real-time PCR.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31269584",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Linc00339 was then found to play a critical role in Huaier-mediated cancer suppression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31781497",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Conclusions: LINC00339 expression is upregulated in colorectal cancer tissues and correlated with patients' clinicopathological features.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31269584",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "tween miR-152 and ROCK1. The role of LINC00339 in tumor formation and metastasis were explored thr",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31081143",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE: To investigate the role and mechanism of long non-coding (lnc) RNA LINC00339 in pancreatic cancer (PANC), and provided a potential target for its biological diagnosis and treatment.METHODS: Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression of LINC00339 in PANC tissue specime",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31128030",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "LINC00339 promotes gastric cancer progression by elevating DCP1A expression via inhibiting miR-377-3p.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31188482",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Our findings highlight the importance of the LINC00339-miR-539-SOX9 pathway in gastric cancer pathogenesis and may point to novel targets for the diagnosis, prognosis, and/or treatment of gastric cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32308105",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "LINC00339 promotes cell proliferation and metastasis in pancreatic cancer via miR-497-5p/IGF1R axis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31128030",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In conclusion, LINC00339 promotes gastric cancer progression by elevating DCP1A expression via inhibiting miR-377-3p.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31188482",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "r transfected with miR-152 mimics. LINC00339 exerted oncogenesis effect on HCC progression by targeting miR-152/ROCK1, and the expression of LINC00339 was negatively correlated with miR-152 expression and positively correlated with ROCK1 ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31081143",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Long noncoding RNA LINC00339 promotes the oncogenicity of gastric cancer by regulating SRY-box 9 expression via sponging of microRNA-539.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32308105",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Long noncoding RNA LINC00339 promotes laryngeal squamous cell carcinoma cell proliferation and invasion via sponging miR-145.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30485513",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In conclusion, our results illuminated that the novel Linc00339/miR-377-3p/HOXC6 axis played a critical role in TNBC progression and might be a promising therapeutic target for TNBC treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Through in vitro and in vivo experiments, Linc00339 overexpression promoted triple-negative breast cancer (TNBC) proliferation, inhibited cell cycle arrest, and suppressed apoptosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Linc00339 was increased in breast cancer cell lines compared with the normal epithelial cell.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "And miR-377-3p was involved in Linc00339-mediated TNBC proliferation through regulating HOXC6 expression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The SP1-Induced Long Noncoding RNA, LINC00339, Promotes Tumorigenesis in Colorectal Cancer via the miR-378a-3p/MED19 Axis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33235461",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We compared the expression levels of Linc00339 in several breast cancer cell lines and normal mammary gland epithelial cell line.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30618083",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "cancer"
}